SAB Biotherapeutics, Inc.

NASDAQ:SABS

1.72 (USD) • At close July 3, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q4
Revenue 00.11500.2630.9450.3051.2670.08602.1613.596.35111.80360.8760000
Cost of Revenue 00.7860.9671.0221.9850.9440.9850.8920.9230.9240.910060.2840000
Gross Profit 0-0.6710-0.759-1.04-0.6390.282-0.80701.2372.686.35111.8030.592-0.336-0.25700
Gross Profit Ratio 0-5.850-2.884-1.101-2.0960.222-9.43400.5730.747110.010000
Reseach & Development Expenses 7.6577.637.8316.88.1244.2974.023.6624.5367.1387.3538.58413.32425.71815.0718.68312.7820
General & Administrative Expenses 3.1152.6713.4793.6434.18914.8812.5712.93.4472.8834.0444.3095.18617.0863.6012.3993.3320
Selling & Marketing Expenses 02.9630-1-1.9630000000000000
SG&A 3.1151.7083.4793.6434.18914.8812.5712.93.4472.8444.0444.3095.18617.0863.6012.3993.3320.009
Other Expenses 0-0.1150-0.263-0.945-0.305-1.267-0.086-0.581-2.161-3.59-6.351-11.803-61.58-14.681-18.21-16.9280
Operating Expenses 10.7729.33811.3099.44310.3518.8745.3235.677.4027.867.8076.5436.70712.6890.3362.873-0.8140.009
Operating Income -10.772-10.009-11.309-10.202-11.391-18.874-5.323-6.477-7.402-7.86-7.807-6.543-6.707-12.689-0.336-2.8730.814-0.009
Operating Income Ratio 0-87.2620-38.77-12.059-61.879-4.2-75.7340-3.637-2.175-1.03-0.568-0.2080000
Total Other Income Expenses Net 5.575-1.3860.962.8666.365-3.9830.221-0.4040.0480.0110.7311.6757.785-4.8960.005-0.0690.5960
Income Before Tax -5.197-11.395-10.349-7.335-5.026-22.857-5.102-6.881-7.354-7.849-7.076-4.8681.078-17.585-0.331-2.9421.41-0.009
Income Before Tax Ratio 0-99.3450-27.877-5.321-74.938-4.026-80.4610-3.632-1.971-0.7670.091-0.2890000
Income Tax Expense 0000-13.37500.1670.07500.026-0.731-0.0920.0920.294-0.0050.0770.0750
Net Income -5.197-11.395-10.349-7.335-5.026-22.857-5.102-6.881-7.354-7.875-7.076-4.7760.986-17.585-4.061-2.9421.41-0.009
Net Income Ratio 0-99.3450-27.877-5.321-74.938-4.026-80.4610-3.644-1.971-0.7520.084-0.2890000
EPS -0.562.45-1.12-0.79-0.54-3.86-0.97-1.36-1.46-1.56-1.6-1.110.23-4.11-0.075-0.680.32-0.006
EPS Diluted -0.562.45-1.12-0.79-0.54-3.86-0.97-1.36-1.46-1.56-1.6-1.110.22-4.11-0.075-0.680.32-0.006
EBITDA -4.349-10.538-9.305-6.187-2.965-21.834-4.047-5.913-6.338-6.838-6.096-4.0161.828-16.146-3.568-2.5671.762-0.009
EBITDA Ratio 0-91.8770-23.513-3.139-71.586-3.193-69.1470-3.164-1.698-0.6320.155-0.2650000